The Munich-based Leading digital HealthTech startup XO Life has raised $7M to fund global platform expansion, with its ImpactMonitorTM offering advanced therapeutic tracking as a tailored substitute for common searches on sites like Google, Facebook, Instagram, or TikTok.
Vi Partners and Bayern Kapital are among the round’s participants, with Sandwater and Grazia Equity acting as the lead investors. Returning participants include Aescuvest, Winning Mindset Ventures, and Isartal Ventures.
XO Life created the ImpactMonitorTM platform, a meta-platform that offers patients reliable health information, therapeutic tracking, and the ability to communicate and support one another as patients.
Dr. Friderike Bruchmann, co-founder and CEO of XO Life, stated:
“We will be able to develop our technology and grow globally thanks to this investment. We are excited to address global health challenges and bring our innovative solutions to a wider audience, having proven our success in the German market.”
When a patient is given a diagnosis or prescription, they have a major need for communication and information. At least once a week, 70% of patients conduct internet research, with Google and Facebook being their first choices. On the other hand, user searches for advertisements and search engine optimization are commonplace in online content. Because of this, only 8 out of 10 patients trust information found online, making them feel insecure and alone.
Related Content: Mental Health AI Startup clare&me Raises €3.7M Funding
A meta-platform created by XO Life acts as a digital companion for patients about their prescription drugs, goods, treatments, and illnesses. Patients can access certified medical information on the platform, which also gathers patient input and so-called patient-reported outcomes. Patients can also benefit from real-world insights from other patients, exchanges, and medical assistance.
Pharma and MedTech companies, along with other healthcare entities, provide their patients with targeted products and therapy areas through the platform. The ImpactMonitorTM platform facilitates the development of novel patient-centered therapeutics by assisting manufacturers and research institutions (the latter at no cost) in identifying the requirements and preferences of patients.
There is no manufacturer sponsorship or exclusive content to guarantee an impartial and free user experience. It’s quick, free, and simple to register on the ImpactMonitorTM platform using a Mac, PC, or the iOS and Android apps.
Investors Thoughts:
Partner at Grazia Equity Jochen Klüppel emphasized:
“XO Life has created and constructed an amazing digital meta-platform. With the support of a robust venture capital consortium, the team combines talent from over 13 countries and possesses technological experience in information technology, natural sciences, and health. Together, they can advance the ImpactMonitorTM platform. The greatest of the finest is what we need to transform an entire sector with!”
Partner at Sandwater Morten E. Iversen gave the following explanation:
“We are excited about the distinctive prospects and possibilities of XO Life’s meta-platform. Further, we are confident that by offering thorough health information and patient support throughout Europe and beyond, the ImpactMonitorTM platform will close a significant gap in the healthcare industry.”
